Zevra Therapeutics to present positive new clinical findings in Niemann-Pick disease type C at CNS symposium

Zevra Therapeutics said positive new clinical findings in Niemann-Pick disease type C will be presented in a podium session at the CNS symposium, adding to its late-stage rare-disease push alongside its Phase 3 vEDS study.

Detected & updated continuously · Source: Nebula